Tumor-inhibiting protein could be effective in treating leukemia

Courtesy EurekAlert! - Medicine and Health  Mon, 07/14/2008 - 23:00

(Temple University) Angiocidin, a tumor-inhibiting novel protein, may also have a role as a new therapeutic application in treating leukemia by inducing a differentiation of monocytic leukemia cells into a normal, macrophage-like phenotype.


 

More related items

Lab study shows methadone breaks resistance in untreatable...
(American Association for Cancer Research) Researchers in Germany have discovered that methadone, an agent used to break addiction to opioid drugs,...

Math could help cure leukemia
(University of Maryland) In a recent study that combined math and medicine, researchers have shown that patients with chronic myelogenous leukemia...

Combination of 2 novel anti-cancer agents may help fight CML...
(Virginia Commonwealth University) Virginia Commonwealth University Massey Cancer Center researchers have identified that a combination of novel...

New drug combination brings 1-2 punch against acute leukemia
(University of Texas M. D. Anderson Cancer Center) Researchers at the University of Texas M. D. Anderson Cancer Center have discovered a drug...

Just Do It: How One Couple Turned Off the TV and Turned On...
Outside of her family and close friends, Annie had not mentioned the sexathon to anybody, which probably was the best way to go. I, however, had...

Lovely by Sarah Jessica Parker Perfume for Women
New in factory retail box .

A Healthy Horse the Natural Way: A Horse Owner's Guide to Using...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com